Sphingolipids in Psychiatric Disorders and Pain Syndromes
Abstract
Despite the high prevalence and devastating impact of psychiatric disorders, little is known about their etiopathology. In this review, we provide an overview on the participation of sphingolipids and enzymes responsible for their metabolism in mechanisms underlying psychiatric disorders. We focus on the pathway from sphingomyelin to proapoptotic ceramide and the subsequent metabolism of ceramide to sphingosine, which is in turn phosphorylated to yield anti-apoptotic sphingosine-1-phosphate (S1P).The sphingomyelinase/ceramide system has been linked to effects of reactive oxygen species and proinflammatory cytokines in the central nervous system as well as to synaptic transmission. Compared to ubiquitously expressed acid sphingomyelinase, acid and neutral ceramidase and neutral sphingomyelinase are highly active in brain regions. Depressed patients show elevated plasma ceramide levels and increased activities of acid sphingomyelinase which is functionally inhibited by many anti-depressive drugs. Exposure to alcohol is associated with an activation of acid and neutral sphingomyelinase observed in cell culture, mouse models and in alcohol-dependent patients and with increased concentrations of ceramide in various organs.Levels of sphingomyelin and ceramide are altered in erythrocytes and post-mortem brain tissues of schizophrenic patients in addition to changes in expression patterns for serine palmitoyltransferase and acid ceramidase leading to impaired myelination. After induction of anxiety-like behavior in animal models, higher serum levels of S1P were reported to lead to neurodegeneration. Correspondingly, S1P infusion appeared to increase anxiety-like behavior. Significantly upregulated levels of the endogenous ceramide catabolite N,N-dimethylsphingosine were observed in rat models of allodynia. Conversely, rats injected intrathecally with N,N-dimethylsphingosine developed mechanical allodynia. Moreover, S1P has been implicated in spinal nociceptive processing.The increasing interest in lipidomics and improved analytical methods led to growing insight into the connection between psychiatric and neurological disorders and sphingolipid metabolism and may once provide new targets and strategies for therapeutic intervention.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Inflammatory cytokines and ROS are implicated in pathophysiology of hypoxia and psychiatric disorders.
“Moreover, inflammatory cytokines and ROS are known to activate sphingosine 1 phosphate and are implicated in pathophysiology of hypoxia and psychiatric disorders (49, 52).”
Inflammatory cytokines and ROS activate sphingosine 1 phosphate.
“Moreover, inflammatory cytokines and ROS are known to activate sphingosine 1 phosphate and are implicated in pathophysiology of hypoxia and psychiatric disorders (49, 52).”
Cites
No health without mental health
Prince, M. J., Patel, V., Saxena, S., Maj, M., Maselko, J., Phillips, M. R., & Rahman, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61238-0 · Cited by 3,835 · see citing works
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766 · see citing works
Belmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166 · see citing works
Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders
Sapolsky, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.925 · Cited by 2,016 · see citing works
The Relationship of Depression to Cardiovascular Disease: Epidemiology, Biology, and Treatment
Musselman, D. L., Evans, D. L., & Nemeroff, C. B. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.7.580 · Cited by 1,532 · see citing works
Biologically active sphingolipids in cancer pathogenesis and treatment
Öğretmen, B., & Hannun, Y. A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1411 · Cited by 1,216 · see citing works
Glial activation: a driving force for pathological pain
Watkins, L. R., Milligan, E. D., & Maier, S. F. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01854-3 · Cited by 1,091 · see citing works
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069 · see citing works
Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review
Potvin, S., Stip, É., Sepehry, A. A., Gendron, A., Bah, R., & Kouassi, É. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.024 · Cited by 989 · see citing works
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M., & Gogos, J. A. (2004) · Nature Genetics · doi:10.1038/ng1296 · Cited by 914 · see citing works
Gao, Y., Zhang, L., Samad, O. A., Suter, M. R., Kawasaki, Y., Xu, Z., Park, J. Y., Lind, A., Ma, Q., & Ji, R. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3623-08.2009 · Cited by 569 · see citing works
Acid sphingomyelinase activity triggers microparticle release from glial cells
Bianco, F., Perrotta, C., Novellino, L., Francolini, M., Riganti, L., Menna, E., Saglietti, L., Schuchman, E. H., Furlan, R., Clementi, E., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.45 · Cited by 550 · see citing works
Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts
Grassmé, H., Jendrossek, V., Riehle, A., von Kürthy, G., Berger, J., Schwarz, H., Weller, M., Kolesnick, R., & Gulbins, E. (2003) · Nature Medicine · doi:10.1038/nm823 · Cited by 536 · see citing works
Self-citationSphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases
Hait, N. C., Oskeritzian, C. A., Paugh, S. W., Milstien, S., & Spiegel, S. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.08.007 · Cited by 478 · see citing works
Oxidative stress in schizophrenia: An integrated approach
Bitanihirwe, B. K. Y., & Woo, T.-U. W. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.008 · Cited by 474 · see citing works
Horrobin, D. F. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00151-5 · Cited by 456 · see citing works
Role of the Serotonergic System in the Pathogenesis of Major Depression and Suicidal Behavior
Mann, J. J. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00040-8 · Cited by 443 · see citing works
Dawkins, J. L., Hulme, D. J., Brahmbhatt, S., Auer‐Grumbach, M., & Nicholson, G. A. (2001) · Nature Genetics · doi:10.1038/85879 · Cited by 421 · see citing works
Crews, F. T., Bechara, R. I., Brown, L. A. S., Guidot, D. M., Mandrekar, P., Oak, S. A., Qin, L., Szabó, G., Wheeler, M. D., & Zou, J. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00084.x · Cited by 414 · see citing works
Lipopolysaccharide Induces Disseminated Endothelial Apoptosis Requiring Ceramide Generation
Haimovitz‐Friedman, A., Cordon‐Cardo, C., Bayoumy, S. S., Garzotto, M. G., McLoughlin, M., Gallily, R., Edwards, C. K., Schuchman, E. H., FUKS, Z. Y., & Kolesnick, R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.11.1831 · Cited by 409 · see citing works
Effects of ethanol on lipid metabolism.
Baraona, E., & Lieber, C. S. (1979) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40613-3 · Cited by 392 · see citing works
Molecular recognition of a single sphingolipid species by a protein’s transmembrane domain
Contreras, F. ‐., Ernst, A. M., Haberkant, P., Björkholm, P., Lindahl, E. R., Gonen, B., Tischer, C., Elofsson, A., von HEIJNE, G., Thiele, C., et al. (2012) · Nature · doi:10.1038/nature10742 · Cited by 373 · see citing works
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
Beaulieu, J., Marion, S., Rodriguiz, R. M., Medvedev, I. O., Sotnikova, T. D., Ghisi, V., Wetsel, W. C., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2008) · Cell · doi:10.1016/j.cell.2007.11.041 · Cited by 362 · see citing works
Oxidative Stress and Alcoholic Liver Disease
Wu, D., & Cederbaum, A. (2009) · Seminars in Liver Disease · doi:10.1055/s-0029-1214370 · Cited by 342 · see citing works
Hofmann, K., Tomiuk, S., Wolff, G., & Stoffel, W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.11.5895 · Cited by 309 · see citing works
Psychoneuroimmunology and the cytokine action in the CNS: Implications for psychiatric disorders
Müller, N., & Ackenheil, M. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(97)00179-6 · Cited by 304 · see citing works
Vectorial Budding of Vesicles by Asymmetrical Enzymatic Formation of Ceramide in Giant Liposomes
Holopainen, J. M., Angelova, M. I., & Kinnunen, P. K. J. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76640-9 · Cited by 295 · see citing works
Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients
Yao, J. K., Leonard, S. S., & Reddy, R. D. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00095-x · Cited by 290 · see citing works
Genome-wide association scan for five major dimensions of personality
Terracciano, A., Sanna, S., Uda, M., Deiana, B., Usala, G., Busonero, F., Maschio, A., Scally, M., Patriciu, N. S., Chen, W.-M., et al. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.113 · Cited by 286 · see citing works
CDT, GGT, and AST As Markers of Alcohol Use: The WHO/ISBRA Collaborative Project
Conigrave, K. M., Degenhardt, L. J., Whitfield, J. B., Saunders, J. B., Helander, A., Tabakoff, B., & on behalf of the WHO/ISBRA Study Group (2002) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02542.x · Cited by 281 · see citing works
Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS
Alexander, G. M., van Rijn, M. A., van Hilten, J. J., Perreault, M. J., & Schwartzman, R. J. (2005) · Pain · doi:10.1016/j.pain.2005.04.013 · Cited by 280 · see citing works
Role of ceramide-activated protein phosphatase in ceramide-mediated signal transduction.
Wolff, R. A., Dobrowsky, R., Bielawska, A., Obeid, L., & Hannun, Y. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32212-3 · Cited by 277 · see citing works
Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction
Chaves, E., & Sipione, S. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.12.010 · Cited by 273 · see citing works
Cloned mammalian neutral sphingomyelinase: Functions in sphingolipid signaling?
Tomiuk, S., Hofmann, K., Nix, M., Zumbansen, M., & Stoffel, W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3638 · Cited by 269 · see citing works
Ceramide-enriched membrane domains—Structure and function
Zhang, Y., Li, X., Becker, K. A., & Gulbins, E. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.07.030 · Cited by 263 · see citing works
Self-citationSchissel, S. L., Keesler, G. A., Schuchman, E. H., Williams, K. J., & Tabas, I. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18250 · Cited by 247 · see citing works
A role for AMPA receptors in mood disorders
Alt, A., Nisenbaum, E. S., Bleakman, D., & Witkin, J. M. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.022 · Cited by 238 · see citing works
Edsall, L. C., Brocklyn, J. R. V., Cuvillier, O., Kleuser, B., & Spiegel, S. (1998) · Biochemistry · doi:10.1021/bi980744d · Cited by 227 · see citing works
Rhinoviruses Infect Human Epithelial Cells via Ceramide-enriched Membrane Platforms
Grassmé, H., Riehle, A., Wilker, B., & Gulbins, E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500835200 · Cited by 226 · see citing works
Self-citationKornhuber, J., Tripal, P., Reichel, M., Terfloth, L., Bleich, S., Wiltfang, J., & Gulbins, E. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070524a · Cited by 225 · see citing works
Self-citationSchwarz, E., Prabakaran, S., Whitfield, P. D., Major, H. J., Leweke, F. M., Koethe, D., McKenna, P. J., & Bahn, S. (2008) · Journal of Proteome Research · doi:10.1021/pr800188y · Cited by 222 · see citing works
Garofalo, K., Penno, A., Schmidt, B. P., Lee, H.-J., Frosch, M. P., von Eckardstein, A., Brown, R. H., Hornemann, T., & Eichler, F. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57549 · Cited by 215 · see citing works
Genetic Determinants of Circulating Sphingolipid Concentrations in European Populations
Hicks, A. A., Pramstaller, P. P., Johansson, Å., Vitart, V., Rudan, I., Ugocsai, P., Aulchenko, Y. S., Franklin, C. S., Liebisch, G., Erdmann, J., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000672 · Cited by 214 · see citing works
Reactive oxygen species limit neutrophil life span by activating death receptor signaling
Scheel‐Toellner, D., Wang, K., Craddock, R. M., Webb, P. R., McGettrick, H. M., Assi, L. K., Parkes, N., Clough, L. E., Gulbins, E., Salmon, M., et al. (2004) · Blood · doi:10.1182/blood-2004-01-0191 · Cited by 208 · see citing works
Self-citationDemirkan, A., van Duijn, C. M., Ugocsai, P., Isaacs, A., Pramstaller, P. P., Liebisch, G., Wilson, J. F., Johansson, Å., Rudan, I., Aulchenko, Y. S., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002490 · Cited by 205 · see citing works
Sphingosine‐1‐Phosphate in Cell Growth and Cell Deatha
Spiegel, S., Cuvillier, O., Edsall, L. C., Kohama, T., Menzeleev, R., Oláh, Z., Olivera, A., Pirianov, G., THOMAS, D. M., Tu, Z., et al. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09658.x · Cited by 203 · see citing works
Sphingomyelinase Treatment Induces ATP-independent Endocytosis
Zha, X., Pierini, L. M., Leopold, P. L., Skiba, P. J., Tabas, I. A., & Maxfield, F. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.1.39 · Cited by 201 · see citing works
Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin
Patti, G. J., Yanes, Ó., Shriver, L. P., Courade, J., Tautenhahn, R., Manchester, M., & Siuzdak, G. E. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.767 · Cited by 196 · see citing works
Enzymic Hydrolysis and Synthesis of Ceramides
Gátt, S. (1963) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51879-2 · Cited by 195 · see citing works
Wheeler, D., Knapp, E., Bandaru, V. V. R., Wang, Y., Knorr, D., Poirier, C., Mattson, M. P., Geiger, J. D., & Haughey, N. J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06038.x · Cited by 194 · see citing works
Ceramidase and ceramide synthesis in human kidney and cerebellum
Sugita, M., Williams, M. A., Dulaney, J. T., & Moser, H. W. (1975) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(75)90176-9 · Cited by 184 · see citing works
Identification of Novel Functional Inhibitors of Acid Sphingomyelinase
Kornhuber, J., Muehlbacher, M., Trapp, S., Pechmann, S., Friedl, A., Reichel, M., Mühle, C., Terfloth, L., Groemer, T. W., Spitzer, G. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023852 · Cited by 175 · see citing works
Self-citationWolf, G., Gabay, E., Tal, M., Yirmiya, R., & Shavit, Y. (2006) · Pain · doi:10.1016/j.pain.2005.11.011 · Cited by 171 · see citing works
Sphingomyelinase activity at pH 7.4 in human brain and a comparison to activity at pH 5.0
Rao, B. G., & Spence, M. W. (1976) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41749-3 · Cited by 170 · see citing works
Demirkan, A., Isaacs, A., Ugocsai, P., Liebisch, G., Struchalin, M., Rudan, I., Wilson, J. F., Pramstaller, P. P., Gyllensten, U., Campbell, H., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.11.001 · Cited by 163 · see citing works
Evidence for white matter abnormalities in schizophrenia
Kubicki, M. R., McCarley, R. W., & Shenton, M. E. (2005) · Current Opinion in Psychiatry · doi:10.1097/00001504-200503000-00004 · Cited by 160 · see citing works
Wong, M., Xie, B., Beatini, N., Phu, P., Marathe, S. V., Johns, A., Gold, P. W., Hirsch, E., Williams, K. J., Licinio, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150098097 · Cited by 157 · see citing works
Toro, C. T., & Deakin, J. F. W. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.003 · Cited by 151 · see citing works
Ono, M., Kikusui, T., Sasaki, N., Ichikawa, M., Mori, Y., & Murakami-Murofushi, K. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.078 · Cited by 149 · see citing works
The Reverse Activity of Human Acid Ceramidase
Okino, N., He, X., Gátt, S., Sandhoff, K., Ito, M., & Schuchman, E. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303310200 · Cited by 147 · see citing works
Sequence variants at CYP1A1–CYP1A2 and AHR associate with coffee consumption
Sulem, P., Gudbjartsson, D. F., Geller, F., Prokopenko, I., Feenstra, B., Aben, K. K. H., Franke, B., den Heijer, M., Kovacs, P. L., Stümvoll, M., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr086 · Cited by 145 · see citing works
High activity of acid sphingomyelinase in major depression
Kornhuber, J., Medlin, A., Bleich, S., Jendrossek, V., Henkel, A. W., Wiltfang, J., & Gulbins, E. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0374-5 · Cited by 143 · see citing works
Self-citationKrut, O., Wiegmann, K., Kashkar, H., Yazdanpanah, B., & Krönke, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511306200 · Cited by 140 · see citing works
Altered thalamic membrane phospholipids in schizophrenia: a postmortem study
Schmitt, A., Wilczek, K., Blennow, K., Maras, A., Jatzko, A., Petroianu, G. A., Braus, D. F., & Gattaz, W. F. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.03.019 · Cited by 134 · see citing works
Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome
Dadabhoy, D., Crofford, L. J., Spaeth, M., Russell, I. J., & Clauw, D. J. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2443 · Cited by 130 · see citing works
The lysosomal localization of sphingolipid hydrolases
Weinreb, N. J., Brady, R. O., & Tappel, A. L. (1968) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(68)90251-9 · Cited by 120 · see citing works
Depression in adults with Fabry disease: A common and under‐diagnosed problem
Cole, A. L., Lee, P., Hughes, D. A., Deegan, P. B., Waldek, S., & Lachmann, R. (2007) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-007-0708-6 · Cited by 120 · see citing works
Evidence for disruption of sphingolipid metabolism in schizophrenia
Narayan, S., Head, S. R., Gilmartin, T. J., Dean, B., & Thomas, E. A. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21822 · Cited by 114 · see citing works
Zhang, Y., Li, X., Carpinteiro, A., & Gulbins, E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4247 · Cited by 109 · see citing works
Self-citationCeramidase Regulates Synaptic Vesicle Exocytosis and Trafficking
Rohrbough, J. C., Rushton, E., Musselman, L. P., Woodruff, E. A., Matthies, H. J. G., Acharya, U. R., Acharya, J., & Broadie, K. S. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1146-04.2004 · Cited by 104 · see citing works
Tabatadze, N., Savonenko, A. V., Song, H., Bandaru, V. V. R., Chu, M., & Haughey, N. J. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22438 · Cited by 101 · see citing works
Lithium blocks the PKB and GSK3 dephosphorylation induced by ceramide through protein phosphatase-2A
Mora, A., Sabio, G., Risco, A. M., Cuenda, A., Alonso, J. C., Soler, G., & Centeno, F. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00282-0 · Cited by 101 · see citing works
Sánchez, C., Rueda, D., Ségui, B., Galve‐Roperh, I., Levade, T., & Guzmán, M. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.955 · Cited by 101 · see citing works
Distribution of alkaline sphingomyelinase activity in human beings and animals
Duan, R. D., Hertervig, E., Nyberg, L., Hauge, T., Sternby, B., Lillienau, J., Farooqi, A., & Nilsson, Å. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02088748 · Cited by 98 · see citing works
Elevated Plasma Ceramides in Depression
Gracia‐García, P., Rao, V., Haughey, N. J., Bandaru, V. V. R., Smith, G. S., Rosenberg, P. B., Lobo, A., Lyketsos, C. G., & Mielke, M. M. (2011) · Journal of Neuropsychiatry · doi:10.1176/jnp.23.2.jnp215 · Cited by 96 · see citing works
Neuropsychiatric Aspects of the Adult Variant of Tay-Sachs Disease
MacQUEEN, G. M., Rosebush, P. I., & Mazurek, M. F. (1998) · Journal of Neuropsychiatry · doi:10.1176/jnp.10.1.10 · Cited by 96 · see citing works
Erythrocyte membrane phospholipids in psychotic patients
Keshavan, M. S., Mallinger, A. G., Pettegrew, J. W., & Dippold, C. S. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90032-c · Cited by 95 · see citing works
Chang, G. H.-F., Barbaro, N. M., & Pieper, R. O. (2000) · Neuro-Oncology · doi:10.1093/neuonc/2.3.174 · Cited by 95 · see citing works
Changes in Levels of Phosphorus Metabolites in Temporal Lobes of Drug-Naive Schizophrenic Patients
Fukuzako, H., Fukuzako, T., Hashiguchi, T., Kodama, S., Takigawa, M., & Fujimoto, T. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.8.1205 · Cited by 92 · see citing works
Counter-Regulation of Opioid Analgesia by Glial-Derived Bioactive Sphingolipids
Muscoli, C., Doyle, T. M., Dagostino, C., Bryant, L., Chen, Z., Watkins, L. R., Ryerse, J. S., Bieberich, E., Neumman, W., & Salvemini, D. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2391-10.2010 · Cited by 92 · see citing works
Ceramide and sphingomyelinases in the regulation of stress responses
Sawai, H., & Hannun, Y. A. (1999) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(99)00082-1 · Cited by 88 · see citing works
Ceramide pathways modulate ethanol‐induced cell death in astrocytes
Pascual, M., Vallés, S. L., Renau‐Piqueras, J., & Guerri, C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02130.x · Cited by 87 · see citing works
Purification and Characterization of a Membrane-bound Nonlysosomal Ceramidase from Rat Brain
Bawab, S. E., Bielawska, A. E., & Hannun, Y. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27948 · Cited by 86 · see citing works
Nie, H., & Weng, H. (2010) · Journal of Neurophysiology · doi:10.1152/jn.00013.2010 · Cited by 82 · see citing works
Liangpunsakul, S., Rahmini, Y., Ross, R. A., Zhao, Z., Xu, Y., & Crabb, D. W. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00455.2011 · Cited by 80 · see citing works
Liangpunsakul, S., Sozio, M. S., Shin, E., Zhao, Z., Xu, Y., Ross, R. A., Zeng, Y., & Crabb, D. W. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00482.2009 · Cited by 79 · see citing works
Hofmeister, R., Wiegmann, K., Korherr, C., Bernardo, K., Krönke, M., & Falk, W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27730 · Cited by 79 · see citing works
Deaciuc, I. V., Nikolova‐Karakashian, M., Fortunato, F., Lee, E. Y., Hill, D. B., & McClain, C. J. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb04575.x · Cited by 78 · see citing works
Ndengele, M. M., Cuzzocrea, S., Masini, E., Vinci, M. C., Esposito, E., Muscoli, C., Petrusca, D. N., Mollace, V., Mazzon, E., Li, D., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146290 · Cited by 72 · see citing works
Marı́, M., Colell, A., Morales, A., Pañeda, C., Varela‐Nieto, I., García‐Ruiz, C., & Fernández-Checa, J. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19852 · Cited by 72 · see citing works
Klein, R., BANSCH, M., & Berg, P. A. (1992) · Psychoneuroendocrinology · doi:10.1016/0306-4530(92)90017-2 · Cited by 70 · see citing works
Sphingomyelin-enriched microdomains define the efficiency of native Ca2+-triggered membrane fusion
Rogasevskaia, T. P., & Coorssen, J. R. (2006) · Journal of Cell Science · doi:10.1242/jcs.03007 · Cited by 69 · see citing works
Davis, C. N., Tabarean, I. V., Gaidarova, S., Behrens, M. M., & Bartfai, T. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03951.x · Cited by 69 · see citing works
Syntaxin 4 Is Required for Acid Sphingomyelinase Activity and Apoptotic Function
Perrotta, C., Bizzozero, L., Cazzato, D., Morlacchi, S., Assi, E., Simbari, F., Zhang, Y., Gulbins, E., Bassi, M. T., Rosa, P., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.139287 · Cited by 66 · see citing works
Self-citationCorcoran, C. A., He, Q., Ponnusamy, S., Öğretmen, B., Huang, Y., & Sheikh, M. S. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2097 · Cited by 60 · see citing works
Sjögren, B., & Svenningsson, P. (2007) · Acta Physiologica · doi:10.1111/j.1365-201x.2007.01687.x · Cited by 59 · see citing works
The role of ceramide in major depressive disorder
Kornhuber, J., Reichel, M., Tripal, P., Groemer, T. W., Henkel, A. W., Mühle, C., & Gulbins, E. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0061-x · Cited by 59 · see citing works
Self-citationThe effects of ethanol ingestion on lipid metabolism
Reitz, R. C. (1979) · Progress in Lipid Research · doi:10.1016/0163-7827(79)90007-9 · Cited by 59 · see citing works
Acid and alkaline ceramidases of rat tissues
Spence, M. W., Beed, S. D., & Cook, H. W. (1986) · Biochemistry and Cell Biology · doi:10.1139/o86-056 · Cited by 57 · see citing works
Jang, S., Suh, S. H., Yoo, H., Lee, Y., & Oh, S. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9523-6 · Cited by 56 · see citing works
Narayan, S., Kass, K. E., & Thomas, E. A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21161 · Cited by 56 · see citing works
de Miranda, A. S., Lacerda‐Queiroz, N., Vilela, M. C., Rodrigues, D. H., Rachid, M. A., Quevedo, J., & Teixeira, A. L. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.01.038 · Cited by 53 · see citing works
Sphingosine 1-Phosphate Modulates Spinal Nociceptive Processing
Coste, O., Brenneis, C., Linke, B., Pierre, S. C., Maeurer, C., Becker, W., Schmidt, H., Gao, W., Geißlinger, G., & Scholich, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806410200 · Cited by 52 · see citing works
Ethanol-Induced Alterations in Fatty Acid-Related Lipids in Serum and Tissues in Mice
Zhao, Z., Yu, M., Crabb, D. W., Xu, Y., & Liangpunsakul, S. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01338.x · Cited by 52 · see citing works
Norman, E. D., Cutler, R. G., Flannery, R. J., Wang, Y., & Mattson, M. P. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06779.x · Cited by 52 · see citing works
Spence, M. W., & Burgess, J. K. (1978) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1978.tb10804.x · Cited by 51 · see citing works
Qin, J., Berdyshev, E. V., Poirer, C., Schwartz, N. B., & Dawson, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.304857 · Cited by 49 · see citing works
Skin Ceramide Alterations in First-Episode Schizophrenia Indicate Abnormal Sphingolipid Metabolism
Smesny, S., Schmelzer, C. E. H., Hinder, A., Köhler, A., Schneider, C., Rudzok, M., Schmidt, U., Milleit, B., Milleit, C., Nenadić, I., et al. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs058 · Cited by 48 · see citing works
Olsson, N., Harding, A., Harper, C., & Salem, N. (1996) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(95)00576-5 · Cited by 47 · see citing works
Activity of Secretory Sphingomyelinase Is Increased in Plasma of Alcohol-Dependent Patients
Reichel, M., Beck, J., Mühle, C., Rotter, A., Bleich, S., Gulbins, E., & Kornhuber, J. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01529.x · Cited by 46 · see citing works
Self-citationSaito, M., Saito, M., Cooper, T. B., & Vadász, C. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000175011.22307.61 · Cited by 46 · see citing works
Spence, M. W., Burgess, J. K., & Sperker, E. R. (1979) · Brain Research · doi:10.1016/0006-8993(79)90308-1 · Cited by 45 · see citing works
Reichel, M., Greiner, E., Richter‐Schmidinger, T., Yedibela, Ö., Tripal, P., Jacobi, A., Bleich, S., Gulbins, E., & Kornhuber, J. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.01064.x · Cited by 44 · see citing works
Self-citationAntinociceptive activity of the S1P‐receptor agonist FTY720
Coste, O., Pierre, S. C., Marian, C., Brenneis, C., Angioni, C., Schmidt, H., Popp, L., Geißlinger, G., & Scholich, K. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00160.x · Cited by 43 · see citing works
Phospholipid patterns of erythrocytes in schizophrenia: relationships to symptomatology
Ponizovsky, A. M., Modai, I., Nechamkin, Y., Barshtein, G., Ritsner, M., Yedgar, S., Lecht, S., & Bergelson, L. D. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00189-4 · Cited by 42 · see citing works
Effect of sphingomyelinase treatment on ligand binding activity of human serotonin1A receptors
Jafurulla, M., Pucadyil, T. J., & Chattopadhyay, A. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.07.007 · Cited by 38 · see citing works
Ceramide-Induced Alterations in Dopamine Transporter Function
Riddle, E. L., Rau, K. S., Topham, M. K., Hanson, G. R., & Fleckenstein, A. E. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02727-9 · Cited by 37 · see citing works
ACTIVATION OF NEUTRAL SPHINGOMYELINASE PARTICIPATES IN ETHANOL-INDUCED APOPTOSIS IN HEP G2 CELLS
Liu, J.-J. (2000) · Alcohol and Alcoholism · doi:10.1093/alcalc/35.6.569 · Cited by 35 · see citing works
Antibodies against serotonin have no diagnostic relevance in patients with fibromyalgia syndrome.
Werle, E., Fischer, H. P., Müller, A., Fiehn, W., & Eich, W. (2001) · PubMed · Cited by 34 · see citing works
Modulation of Sphingosine 1-Phosphate and Tyrosine Hydroxylase in the Stress-Induced Anxiety
Jang, S., Kim, D., Lee, Y., Moon, S., & Oh, S. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0313-1 · Cited by 32 · see citing works
GM1 ganglioside reduces ethanol intoxication and the development of ethanol dependence
Wallis, C. J., Rezazadeh, S. M., & Lal, H. (1995) · Alcohol · doi:10.1016/0741-8329(95)02005-5 · Cited by 31 · see citing works
Cholesterol and sphingolipids in alcohol‐induced liver injury
Fernández, A., Colell, A., García‐Ruiz, C., & Fernández-Checa, J. C. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05280.x · Cited by 31 · see citing works
Doyle, T. M., Chen, Z., Obeid, L. M., & Salvemini, D. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.05.018 · Cited by 30 · see citing works
ACTIVATION OF NEUTRAL SPHINGOMYELINASE BY IL-1β REQUIRES THE TYPE 1 INTERLEUKIN 1 RECEPTOR
Nalivaeva, N. N., Георгиевна, Р. Е., Pivanovich, I. Y., Kozinets, I. A., Николаевич, Ш. С., & Bartfai, T. (2000) · Cytokine · doi:10.1006/cyto.1999.0547 · Cited by 30 · see citing works
ESTIMATION OF GLYCOLIPIDS IN FOUR SELECTED LOBES OF HUMAN BRAIN IN NEUROLOGICAL DISEASES1
Cherayil, G. D. (1969) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1969.tb08980.x · Cited by 29 · see citing works
Identification of Multiple Forms of Membrane‐Associated Neutral Sphingomyelinase in Bovine Brain
Jung, S. Y., Suh, J. H., Park, H. J., Jung, K., Kim, M. Y., Na, D. S., & Kim, D. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751004.x · Cited by 27 · see citing works
The genetic basis for psychiatric illness in man*
Tandon, K., & McGuffin, P. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02095.x · Cited by 26 · see citing works
HITZEMANN, R. J., Mark, C., Hirschowitz, J., & Garver, D. L. (1985) · Biological Psychiatry · doi:10.1016/0006-3223(85)90042-3 · Cited by 24 · see citing works
Glasier, M. M., SUTTON, R. L., & Stein, D. G. (1995) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1995.0003 · Cited by 23 · see citing works
Demisch, L., Heinz, K., Gerbaldo, H., & Kirsten, R. (1992) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(92)90058-q · Cited by 23 · see citing works
Spinal ceramide and neuronal apoptosis in morphine antinociceptive tolerance
Bryant, L., Doyle, T. M., Chen, Z., Cuzzocrea, S., Masini, E., Vinci, M. C., Esposito, E., Mazzon, E., Petrusca, D. N., Petrache, I., et al. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.07.051 · Cited by 22 · see citing works
Ethanol Increases the Neurotoxic Effect of Tumor Necrosis Factor‐α in Cultured Rat Astrocytes
DeVito, W. J., Stone, S., & Shamgochian, M. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb04557.x · Cited by 19 · see citing works
Neutral sphingomyelinase 2 induces dopamine uptake through regulation of intracellular calcium
Kim, S. K., Ahn, K. H., Ji, J. E., Choi, J. M., Jeon, H. J., Jung, S. Y., Jung, K., & Kim, D. K. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.01.012 · Cited by 18 · see citing works
Gilmore, N., Cherian, L., & Klemm, W. R. (1991) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(91)90044-2 · Cited by 16 · see citing works
Platelet‐activating factor modulates brain sphingomyelin metabolism
Latorre, E., Aragonés, M. D., Fernández, I., & Catalán, R. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00358.x · Cited by 14 · see citing works
Lesch, P., SCHMIDT, E., & Schmidt, F. W. (1973) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1973.11.4.159 · Cited by 14 · see citing works
Multiple Actions of Dimethylsphingosine in 1321N1 Astrocytes
Lee, Y.-K., Kim, H.-L., Kim, Y.-L., & Im, D. (2007) · Molecules and Cells · doi:10.1016/s1016-8478(23)07383-1 · Cited by 13 · see citing works
Thayyullathil, F., Chathoth, S., Hago, A., Patel, M. C., Szulc, Z. M., Hannun, Y. A., & Galadari, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.12.012 · Cited by 12 · see citing works
Zhang, H., Li, D., Su, Y., Jiang, S., Xu, Y., Jiang, K., & Cui, D. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.559273 · Cited by 11 · see citing works
Effects of Chronic Alcohol Abuse on the Fatty Acid Composition of Major Lipids in the Human Brain
Lesch, P., Schmidt, E. M., & Schmidt, F. W. (1973) · Cited by 9 · see citing works
Abnormality of gangliosides in erythrocyte membranes of schizophrenic patients.
Haselhorst, U., Schenk, H., Beyer, I., Uebelhack, R., Franke, E., & Kielstein, V. (1988) · PubMed · Cited by 9 · see citing works
Chang, G. H.-F., Barbaro, N. M., & Pieper, R. O. (2000) · Neuro-Oncology · doi:10.1215/s1522851700000168 · Cited by 8 · see citing works
Levade, T., Salvayre, R., Potier, M., & Douste‐Blazy, L. (1986) · Neurochemical Research · doi:10.1007/bf00965942 · Cited by 6 · see citing works
Membranes, Methylation and Lithium Responsive Psychoses
Hitzemann, R., Hirschowitz, J., Panini, A., Mark, C., & Garver, D. (1984) · Nutrition and Health · doi:10.1177/026010618400300304 · Cited by 4 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Britten, C. D., Garrett-Mayer, E. S., Chin, S. H., Shirai, K., Öğretmen, B., Bentz, T. A., Brisendine, A., Anderton, K., Cusack, S., Maines, L. W., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2363 · Cited by 168 · see citing works
The ceramide system as a novel antidepressant target
Kornhuber, J., Müller, C. P., Becker, K. A., Reichel, M., & Gulbins, E. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.04.003 · Cited by 121 · see citing works
Self-citationNemkov, T. G., Reisz, J. A., Xia, Y., Zimring, J. C., & D’Alessandro, A. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1531710 · Cited by 113 · see citing works
Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases
Grassi, S., Mauri, L., Prioni, S., Cabitta, L., Sonnino, S., Prinetti, A., & Giussani, P. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00807 · Cited by 109 · see citing works
Sphingosine-1-phosphate receptor therapies: Advances in clinical trials for CNS-related diseases
O’Sullivan, S. A., & Dev, K. K. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.11.006 · Cited by 105 · see citing works
Lipids as biomarkers of brain disorders
Hussain, G., Anwar, H., Rasul, A., Imran, A., Qasim, M., Zafar, S., Imran, M., Kamran, S., Aziz, N., Razzaq, A., et al. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1529653 · Cited by 105 · see citing works
Ceramides and depression: A systematic review
Dinoff, A., Herrmann, N., & Lanctôt, K. L. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.02.008 · Cited by 95 · see citing works
Rahimian, R., Belliveau, C., Chen, R., & Mechawar, N. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.871997 · Cited by 73 · see citing works
Fonteh, A. N., Ormseth, C. H., Chiang, J., Cipolla, M., Arakaki, X., & Harrington, M. G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125597 · Cited by 72 · see citing works
Wigger, D., Gulbins, E., Kleuser, B., & Schumacher, F. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00210 · Cited by 65 · see citing works
Self-citationThe Impact of Dietary Sphingolipids on Intestinal Microbiota and Gastrointestinal Immune Homeostasis
Rohrhofer, J., Zwirzitz, B., Selberherr, E., & Untersmayr, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.635704 · Cited by 64 · see citing works
Bioactive lipids as modulators of immunity, inflammation and emotions
Chiurchiù, V., & Maccarrone, M. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.06.005 · Cited by 64 · see citing works
Xing, Y., Tang, Y., Zhao, L., Wang, Q., Qin, W., Ji, X., Zhang, J., & Jia, J. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.09.028 · Cited by 63 · see citing works
Castillo-Passi, R. I., Rojo, L. E., Henríquez‐Henríquez, M., Hernán Silva, I., Maturana, A., Villar, M. J., Fuentes, M., & Gaspar, P. A. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00488 · Cited by 52 · see citing works
Kalinichenko, L. S., Mühle, C., Jia, T., Anderheiden, F., Datz, M., Eberle, A.-L., Eulenburg, V., Granzow, J., Hofer, M., Hohenschild, J., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01304-w · Cited by 43 · see citing works
Self-citationSomvanshi, P. R., Mellon, S. H., Flory, J. D., Abu-Amara, D., PTSD Systems Biology Consortium;, Wolkowitz, O. M., Yehuda, R., Jett, M., Hood, L., Marmar, C., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00065.2019 · Cited by 40 · see citing works
Mitchell, E. J., Klein, S. L., Argyropoulos, K. V., Sharma, A., Chan, R., Toth, J. G., Barboza, L., Bavley, C. C., Bortolozzi, A. A., Chen, Q., et al. (2016) · Nature Communications · doi:10.1038/ncomms11492 · Cited by 38 · see citing works
Rao, X., Thapa, K. S., Chen, A. B., Lin, H., Gao, H., Reiter, J. L., Gallaway, K. A., Ipe, J., Lai, D., Xuei, X., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0508-z · Cited by 37 · see citing works
Filho, A. J. M. C., Braniff, O., Angelova, A., Deng, Y., & Tremblay, M. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110702 · Cited by 39 · see citing works
Mühle, C., Weinland, C., Gulbins, E., Lenz, B., & Kornhuber, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124028 · Cited by 37 · see citing works
Self-citationMühle, C., Wagner, C., Färber, K., Richter‐Schmidinger, T., Gulbins, E., Lenz, B., & Kornhuber, J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060846 · Cited by 36 · see citing works
Self-citationImportin α5 Regulates Anxiety through MeCP2 and Sphingosine Kinase 1
Panayotis, N., Sheinin, A., Dagan, S. Y., Tsoory, M., Rother, F., Vadhvani, M., Meshcheriakova, A., Koley, S., Marvaldi, L., Song, D., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.066 · Cited by 35 · see citing works
Wu, H., Zhang, Q., Gao, J., Sun, C., Wang, J., Xia, W. T., Cao, Y., Hao, Y., & Wu, L. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4805-4 · Cited by 35 · see citing works
Sphingolipids as Biomarkers of Disease
Matanes, F., Twal, W. O., & Hammad, S. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-21162-2_7 · Cited by 34 · see citing works
Looking into the genetic bases of OCD dimensions: a pilot genome-wide association study
Alemany-Navarro, M., Cruz, R., Real, E., Segalàs, C., Bertolín, S., Rabionet, R., Carracedo, Á., Menchón, J. M., & Alonso, P. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0804-z · Cited by 31 · see citing works
Sphingomyelin Synthases in Neuropsychiatric Health and Disease
Mühle, C., Canalejas, R. D. B., & Kornhuber, J. (2019) · Neurosignals · doi:10.33594/000000200 · Cited by 29 · see citing works
Self-citationZoicas, I., Mühle, C., Schmidtner, A. K., Gulbins, E., Neumann, I. D., & Kornhuber, J. (2020) · Cells · doi:10.3390/cells9051239 · Cited by 29 · see citing works
Self-citationSphingolipid and Endocannabinoid Profiles in Adult Attention Deficit Hyperactivity Disorder
Brunkhorst-Kanaan, N., Trautmann, S., Schreiber, Y., Thomas, D., Kittel-Schneider, S., Gurke, R., Geisslinger, G., Reif, A., & Tegeder, I. (2021) · Biomedicines · doi:10.3390/biomedicines9091173 · Cited by 25 · see citing works
Wesseling, H., Xu, B., Want, E. J., Holmes, E. C., Guest, P. C., Karayiorgou, M., Gogos, J. A., & Bahn, S. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.27 · Cited by 25 · see citing works
Simone, R. D., Butera, A., Armida, M., Pèzzola, A., Boirivant, M., Potenza, R. L., & Ricceri, L. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.03.041 · Cited by 22 · see citing works
Collins, J. M., Caputi, V., Manurung, S., Gross, G., Fitzgerald, P., Golubeva, A. V., Popov, J., Deady, C., Dinan, T. G., Cryan, J. F., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109026 · Cited by 22 · see citing works
The ceramide-S1P pathway as a druggable target to alleviate peripheral neuropathic pain
Langeslag, M., & Kress, M. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1787989 · Cited by 21 · see citing works
Dysregulation of sphingolipid metabolism in pain
Wang, J., Zheng, G., Wang, L., Meng, L., Ren, J., Shang, L., Li, D., & Bao, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1337150 · Cited by 14 · see citing works
Luarte, A., Nardocci, G., Chakraborty, A., Bátiz, L. F., Pino‐Lagos, K., & Wyneken, Ú. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106833 · Cited by 12 · see citing works
Okeoma, C. M., Naushad, W., Okeoma, B. C., Gartner, C. A., Santos-Ortega, Y., Vary, C., Bastos, S., Carregari, V. C., Larsen, M. R., Noghero, A., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03512-2 · Cited by 12 · see citing works
Zoicas, I., Mühle, C., Schumacher, F., Kleuser, B., & Kornhuber, J. (2023) · Cells · doi:10.3390/cells12101355 · Cited by 11 · see citing works
Self-citationPan, F., Liu, M., Randell, E. W., Rahman, P., Jones, G., & Zhai, G. (2020) · Pain · doi:10.1097/j.pain.0000000000002163 · Cited by 11 · see citing works
Lipid and metabolic alteration involvement in physiotherapy for chronic nonspecific low back pain
Zhang, Z., Zhang, C., Li, Y., Wang, C., & Yu, Q. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01737-4 · Cited by 10 · see citing works
Kar, S. S., Gharai, S. R., Sahu, S. K., Ravichandiran, V., & Swain, S. P. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266288509240422112839 · Cited by 10 · see citing works
Fischer, C., Thomas, D., Gurke, R., & Tegeder, I. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-03012-0 · Cited by 9 · see citing works
Vogel, A., Ueberbach, T., Wilken‐Schmitz, A., Hahnefeld, L., Franck, L., Weyer, M.-P., Jungenitz, T., Schmid, T., Buchmann, G., Freudenberg, F., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01106-3 · Cited by 7 · see citing works
Zhang, J., Ren, R., Ding, S., Sa, Y., Zhang, W., Wang, W., Wilson, G., Ma, X., & Gong, K. (2024) · Biomedical Chromatography · doi:10.1002/bmc.6029 · Cited by 6 · see citing works
Bie, X., Zhang, M., Wang, Q., & Wang, Y. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106852 · Cited by 6 · see citing works
Labus, J. S., Mayer, E. A., Tillisch, K., Aagaard, K. M., Stains, J., Broniowska, K., Remortel, C. V., Tun, G., & Rapkin, A. J. (2021) · Journal of Pain · doi:10.1016/j.jpain.2021.04.017 · Cited by 6 · see citing works
Characterization of a Neutral Sphingomyelinase Activity in Human Serum and Plasma
Mühle, C., & Kornhuber, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032467 · Cited by 6 · see citing works
Self-citationXu, H. S., Chen, Y., Patel, A. R., Wang, Z., McDonough, C. M., & Guo, T. L. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122259 · Cited by 5 · see citing works
Hahnefeld, L., Hackel, J., Trautmann, S., Angioni, C., Schreiber, Y., Gurke, R., Thomas, D., Wicker, S., Geißlinger, G., & Tegeder, I. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00630.2024 · Cited by 4 · see citing works
Yuan, H., Xu, Y., Jiang, H., Jiang, M., Zhang, L., Wei, S., Cao, L., & Zhigang, Z. (2025) · Molecular Brain · doi:10.1186/s13041-025-01178-x · Cited by 4 · see citing works
Somvanshi, P. R., Mellon, S. H., Flory, J. D., Amara, D. A., Wolkowitz, O. M., Yehuda, R., Jett, M., Marmar, C. R., Doyle, F. J., Hood, L., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/492827 · Cited by 4 · see citing works
Brazdis, R.-M., Zoicas, I., Kornhuber, J., & Mühle, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168685 · Cited by 3 · see citing works
Self-citationГромова, О. А., & Torshin, I. Y. (2023) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2023-3-128-138 · Cited by 2 · see citing works
Role of PAR-4 in Ceramide-Inducible Effects in Neurodegeneration
Elsherbini, A. M., & Bieberich, E. (2021) · Springer eBooks · doi:10.1007/978-3-030-80558-6_13 · Cited by 1 · see citing works
Genome Wide Analysis Identifies Sphingolipid Metabolism As A New Target Of Valproic Acid
Jadhav, S. (2016) · Human Biology
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00003-3
Repetitive and compulsive behavior after Early-Life-Pain in micePreprint
Vogel, A., Ueberbach, T., Wilken‐Schmitz, A., Hahnefeld, L., Franck, L., Weyer, M.-P., Jungenitz, T., Schmid, T., Buchmann, G., Freudenberg, F., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2560826/v1
Hahnefeld, L., Hackel, J., Trautmann, S., Angioni, C., Schreiber, Y., Gurke, R., Thomas, D., Wicker, S., Geißlinger, G., & Tegeder, I. (2024) · Research Square · doi:10.21203/rs.3.rs-4408378/v1
Jimenez, L. B. P., Prislovsky, A., Parchejo, L. A., Cabrera, K., Nafziger, A. J., Stephenson, D., Chalfant, C. E., Aenlle, K. K., Klimas, N. G., Tang, F., et al. (2025) · Biomolecules · doi:10.3390/biom15121716
Wang, L., Lu, C., Sun, X., Sun, W., Han, Y., Zhou, Z., Li, Y., Liu, N., Wang, X., Li, S., et al. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-026-02358-z
Hoffmann, A., Allwright, M., Guennewig, B., Rohleder, C., Jieu, B., Koethe, D., Dammann, I., del Castillo, A. A., Mueller, J. K., Enning, F., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03933-5
- Authors
- Mühle, C., Reichel, M., Gulbins, E., & Kornhuber, J.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Duisburg-Essen (DE)
- Corresponding author
- Kornhuber, J.
- Venue
- Handbook of Experimental Pharmacology
- Publisher
- Springer Vienna
- Published
- 2013
- Issue
- 216
- Pages
- 431-456
- ISSN
- 0171-2004 (ISSN-L)
- 1865-0325
- OpenAlex
- W129745045
- Cited by
- 58
- References
- 146
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 7 · 2023: 8 · 2022: 3 · 2021: 5 · 2020: 5 · 2019: 8 · 2018: 4 · 2017: 4 · 2016: 7 · 2015: 1 · 2014: 1
- FWCI
- 3.94
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- Locations
- Handbook of experimental pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
- Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
- Keywords
- sphingolipids, sphingolipid metabolism, mental illness, pain syndromes, ceramide, sphingomyelin, sphingosine-1-phosphate, acid sphingomyelinase, neutral sphingomyelinase, ceramidase, acid ceramidase, serine palmitoyltransferase, N,N-dimethylsphingosine, allodynia, anxiety-like behavior, depression, alcoholism, schizophrenia, neurodegeneration, reactive oxygen species, inflammatory cytokines, synaptic transmission, lipidomics, myelination
- MeSH terms
- Animals, Mental Disorders, Brain, Ceramides, Humans, Pain, Sphingolipids, Sphingomyelin Phosphodiesterase, Sphingomyelins, Syndrome, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review